CLINICAL_TRIALS trial_result · 2021-07-01

Clinical Trial Update: A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee [Phase 2]

Phase 2 trial of REGN5069 in knee osteoarthritis was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis of the Knee, Pain | Phase 2 | Status: TERMINATED | Results posted: 2021-07-01